These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 1855439

  • 1. Possible mechanism of proteolysis for the extrapancreatic action of tolbutamide.
    Matsutani A, Kaku K, Aoki M, Mori K, Matsuda M, Kaneko T.
    Diabetes Res Clin Pract; 1991 Apr; 12(1):35-40. PubMed ID: 1855439
    [Abstract] [Full Text] [Related]

  • 2. Effects of tolbutamide on fructose-2,6-bisphosphate formation and ketogenesis in hepatocytes from diabetic rats.
    Mori K, Kaku K, Inoue H, Aoki M, Matsutani A, Kaneko T.
    Metabolism; 1992 Jul; 41(7):706-10. PubMed ID: 1535678
    [Abstract] [Full Text] [Related]

  • 3. Tolbutamide and insulin stimulation of fructose-2,6-bisphosphate formation in hepatocytes differ.
    Matsuda M, Kaku K, Hatao K, Kaneko T.
    Diabetes Res Clin Pract; 1986 Jul; 2(6):347-51. PubMed ID: 3545724
    [Abstract] [Full Text] [Related]

  • 4. Tolbutamide stimulates fructose-2, 6-bisphosphate formation in perfused rat liver.
    Matsutani A, Kaku K, Kaneko T.
    Diabetes; 1984 May; 33(5):495-8. PubMed ID: 6547102
    [Abstract] [Full Text] [Related]

  • 5. Tolbutamide enhances insulin action on gluconeogenesis and on fructose 2,6-bisphosphate levels in isolated rat hepatocytes.
    Monge L, Cabello MA, Samper B, Mojena M, Felíu JE.
    Diabete Metab; 1988 Dec; 14(6):712-6. PubMed ID: 2977593
    [Abstract] [Full Text] [Related]

  • 6. Sulfonylurea stimulates liver fructose-2,6-bisphosphate formation in proportion to its hypoglycemic action.
    Hatao K, Kaku K, Matsuda M, Tsuchiya M, Kaneko T.
    Diabetes Res Clin Pract; 1985 Mar; 1(1):49-53. PubMed ID: 3939113
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of tolbutamide on fructose-6-phosphate,2-kinase and fructose-2,6-bisphosphatase in rat liver.
    Kaku K, Matsuda M, Matsutani A, Kaneko T.
    Biochem Biophys Res Commun; 1986 Sep 14; 139(2):687-92. PubMed ID: 3021137
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Studies on the effects of protease substrate analogues on some of the actions of insulin.
    Begum N, Tepperman HM, Tepperman J.
    Biochem Biophys Res Commun; 1985 Jan 16; 126(1):489-95. PubMed ID: 3882089
    [Abstract] [Full Text] [Related]

  • 13. Activation of glycolysis by insulin with a sequential increase of the 6-phosphofructo-2-kinase activity, fructose-2,6-bisphosphate level and pyruvate kinase activity in cultured rat hepatocytes.
    Probst I, Unthan-Fechner K.
    Eur J Biochem; 1985 Dec 02; 153(2):347-53. PubMed ID: 3000776
    [Abstract] [Full Text] [Related]

  • 14. Tolbutamide inhibits cAMP-dependent phosphorylation of liver 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.
    Aoki M, Kaku K, Inoue H, Matsutani A, Kaneko T.
    Diabetes; 1992 Mar 02; 41(3):334-8. PubMed ID: 1312965
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of glipizide on hepatic fructose 2,6-bisphosphate concentration and glucose metabolism.
    Cabello MA, Monge L, Ortega JL, Samper B, Felíu JE.
    Metabolism; 1987 Aug 02; 36(8):738-42. PubMed ID: 3037236
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evidence for dissociation of gluconeogenesis stimulated by non-esterified fatty acids and changes in fructose 2,6-bisphosphate in cultured rat hepatocytes.
    Clore JN, Stillman JS, Helm ST, Blackard WG.
    Biochem J; 1992 Nov 15; 288 ( Pt 1)(Pt 1):145-8. PubMed ID: 1445259
    [Abstract] [Full Text] [Related]

  • 20. CS-045, a new oral antidiabetic agent, stimulates fructose-2,6-bisphosphate production in rat hepatocytes.
    Murano K, Inoue Y, Emoto M, Kaku K, Kaneko T.
    Eur J Pharmacol; 1994 Mar 21; 254(3):257-62. PubMed ID: 8013560
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.